Renoprotective effects of renin-angiotensin-system inhibitors [5]

Lancet

Volumn 367, Issue 9514, 2006, Pages 900-

  Mann, Johannes F E ^a   Ritz, Eberhard ^b   Kunz, Regina ^c  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ALBUMINURIA; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CLINICAL PRACTICE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DISEASE COURSE; DRUG EFFECT; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; LETTER; META ANALYSIS; POST HOC ANALYSIS; PRIORITY JOURNAL; PROTEINURIA; REGRESSION ANALYSIS; RENAL PROTECTION; RISK REDUCTION; SYSTEMATIC REVIEW;

EID: 33645000740     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)68375-X     Document Type: Letter

References (5)

1. JP Casas, W Chua, S Loukogeorgakis Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis Lancet 366 2005 2026 2033
2. TH Jafar, PC Stark, CH Schmid Progression of kidney disease: the role of blood pressure control, proteinuria, and ACE inhibition: a patient-level metaanalysis Ann Intern Med 135 2003 73 87
3. S Klahr, AS Levey, GJ Beck The effects of dietary protein restriction and blood pressure control in the progression of chronic renal disease N Engl J Med 330 1994 877 884
4. LY Agodoa, L Appel, GL Bakris Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial J Am Med Assoc 285 2001 2719 2728
5. N Nakao, A Yoshimura, H Morita Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial Lancet 361 2003 117 124